These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 28068084)
21. Exploring the inhibition mechanism of adenylyl cyclase type 5 by n-terminal myristoylated Gαi1. van Keulen SC; Rothlisberger U PLoS Comput Biol; 2017 Sep; 13(9):e1005673. PubMed ID: 28892485 [TBL] [Abstract][Full Text] [Related]
22. International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases. Dessauer CW; Watts VJ; Ostrom RS; Conti M; Dove S; Seifert R Pharmacol Rev; 2017 Apr; 69(2):93-139. PubMed ID: 28255005 [TBL] [Abstract][Full Text] [Related]
23. Crystal structure of human soluble adenylate cyclase reveals a distinct, highly flexible allosteric bicarbonate binding pocket. Saalau-Bethell SM; Berdini V; Cleasby A; Congreve M; Coyle JE; Lock V; Murray CW; O'Brien MA; Rich SJ; Sambrook T; Vinkovic M; Yon JR; Jhoti H ChemMedChem; 2014 Apr; 9(4):823-32. PubMed ID: 24616449 [TBL] [Abstract][Full Text] [Related]
24. Molecular modeling of manganese regulation of calmodulin-sensitive adenylyl cyclase from mammalian sperm. Toscano WA; Toscano JS; Toscano DG; Gross MK Biochem Biophys Res Commun; 2003 Dec; 312(1):91-6. PubMed ID: 14630024 [TBL] [Abstract][Full Text] [Related]
25. Discovery of novel adenylyl cyclase inhibitor by cell-based screening. Mano H; Ishimoto T; Okada T; Toyooka N; Mori H Biol Pharm Bull; 2014; 37(10):1689-93. PubMed ID: 25273392 [TBL] [Abstract][Full Text] [Related]
26. Structural basis for the high-affinity inhibition of mammalian membranous adenylyl cyclase by 2',3'-o-(N-methylanthraniloyl)-inosine 5'-triphosphate. Hübner M; Dixit A; Mou TC; Lushington GH; Pinto C; Gille A; Geduhn J; König B; Sprang SR; Seifert R Mol Pharmacol; 2011 Jul; 80(1):87-96. PubMed ID: 21498658 [TBL] [Abstract][Full Text] [Related]
27. The interactions of adenylate cyclases with P-site inhibitors. Dessauer CW; Tesmer JJ; Sprang SR; Gilman AG Trends Pharmacol Sci; 1999 May; 20(5):205-10. PubMed ID: 10354616 [TBL] [Abstract][Full Text] [Related]
28. Enzymatic preparation of 32P-labeled beta-L-2',3',-dd-5'ATP and its use as a high-affinity, conformation-specific ligand for labeling adenylyl cyclases. Johnson RA; Shoshani I; Dessauer C; Gosselin G Nucleosides Nucleotides; 1999; 18(4-5):839-42. PubMed ID: 10432690 [TBL] [Abstract][Full Text] [Related]
29. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition. Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193 [TBL] [Abstract][Full Text] [Related]
30. Ca2+-induced inhibition of adenylyl cyclase in turkey erythrocyte membranes. Demirel E; Ugur O; Onaran HO Pharmacology; 1998 Oct; 57(4):222-8. PubMed ID: 9730780 [TBL] [Abstract][Full Text] [Related]
32. Origin of asymmetry in adenylyl cyclases: structures of Mycobacterium tuberculosis Rv1900c. Sinha SC; Wetterer M; Sprang SR; Schultz JE; Linder JU EMBO J; 2005 Feb; 24(4):663-73. PubMed ID: 15678099 [TBL] [Abstract][Full Text] [Related]
33. Structural analysis of human soluble adenylyl cyclase and crystal structures of its nucleotide complexes-implications for cyclase catalysis and evolution. Kleinboelting S; van den Heuvel J; Steegborn C FEBS J; 2014 Sep; 281(18):4151-64. PubMed ID: 25040695 [TBL] [Abstract][Full Text] [Related]